Dear USC Research Community,
I am pleased to share the appointment of Dr. Steven Moldin as Interim Associate Vice President of Research Strategy and Innovation (AVP-RSI) in the USC Research and Innovation (R&I), effective immediately.
As AVP-RSI, Dr. Moldin will be responsible for overseeing the functions of the Office of Research Advancement (ORA), Stevens Center for Innovation, Research Initiatives and Infrastructure (RII), and Alfred E. Mann Institute for Biomedical Engineering. This internal reorganization will enhance efficiency of OOR by integrating and streamlining service and strategic vision across the research development pipeline. Dr. Moldin assumes his new role while maintaining his current responsibilities in ORA.
Dr. Moldin received his B.A. magna cum laude with distinction and Phi Beta Kappa in Psychology from Boston University, his M.A. in Psychology from Yeshiva University, and his Ph.D. in Clinical Psychology from Yeshiva University. He conducted research at New York State Psychiatric Institute/Columbia University and was on faculty at Washington University School of Medicine in St. Louis. In 1995, Dr. Moldin joined the National Institute of Mental Health (NIMH), one of the National Institutes of Health. He led the Office of Human Genetics and Genomic Resources and served as Associate Director of the Division of Neuroscience and Basic Behavioral Science. Dr. Moldin was responsible for the fiscal and scientific management of a $200 million extramural grants and contracts portfolio.
Dr. Moldin has published over 50 papers, including articles in Nature Genetics and the Journal of Neuroscience, as well as book chapters in the areas of psychiatric genetics, schizophrenia, autism, and neuroscience. He is co-editor of the books Methods in Genomic Neuroscience and Understanding Autism: From Basic Neuroscience to Treatment.
Dr. Moldin has served as Executive Director of ORA since its inception in 2006. Under Dr. Moldin’s leadership, ORA has contributed to the submission of over 1,000 proposals to multiple federal funding agencies, of which over 300 have been funded for a total of $850 million.
Please join me in welcoming Dr. Moldin in his new role as Interim Associate Vice President of Research Strategy and Innovation.
Sincerely,
Ishwar K. Puri
Vice President of Research and Professor